TOP TIERMARKET NEWSWIRE
News & sentiment

EPLUS INC (PLUS) — News & AI sentiment

EPLUS INC (PLUS) news roundup. 8 stories aggregated over the last 30 days. Average 30-day sentiment is 59.5/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 6 sales totalling $1.3M — net selling of $1.3M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
8
avg sentiment 59.5/100
Insider net (90d)
$1.3M
0 buys · 6 sells
Congress (90d)
0
0 buys · 0 sells

PLUS news in the last 24 hours, 7 days, 30 days and 90 days

How much PLUS coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowPLUS storiesAvg AI sentimentRead
Last 24 hours0no coverage
Last 7 days0no coverage
Last 30 days859.5/100PLUS headlines →
Last 90 days3256.9/100PLUS headlines →

Latest stories on PLUS

PlusAI to go public in $800M SPAC deal
Seeking Alpha65 · bullishgeneral
Sep 3
Sep 3
Sep 3
Sep 2
Sep 1
Aug 31
Aug 27
Aug 24
Aug 6
Aug 6
ePlus declares $0.27 dividend
Seeking Alpha50 · neutralgeneral
Aug 5
Aug 4
ePlus inc. (PLUS) Q1 2027 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Aug 4
EPLUS INC (PLUS) files 8-K
SEC 8-K50 · neutralgeneral
Aug 4
Aug 4
Aug 4
Jul 28
Jul 28
Jul 24
Jul 21
EPLUS INC (PLUS) files 8-K
SEC 8-K50 · neutralgeneral
Jul 6
Jul 6
ePlus Appoints John Lutz to Board of Directors
PR Newswire50 · neutralgeneral
Jul 6
Jul 1
Jun 30
Open PLUS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →